Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Intangibles (2016 - 2026)

Phibro Animal Health has reported Intangibles over the past 13 years, most recently at $33.1 million for Q4 2025.

  • For Q4 2025, Intangibles fell 17.12% year-over-year to $33.1 million; the TTM value through Dec 2025 reached $33.1 million, down 17.12%, while the annual FY2025 figure was $36.5 million, 75.36% down from the prior year.
  • Intangibles for Q4 2025 was $33.1 million at Phibro Animal Health, down from $35.0 million in the prior quarter.
  • Over five years, Intangibles peaked at $150.0 million in Q2 2023 and troughed at $33.1 million in Q4 2025.
  • A 5-year average of $69.4 million and a median of $57.4 million in 2021 define the central range for Intangibles.
  • Biggest five-year swings in Intangibles: surged 94.19% in 2021 and later crashed 75.36% in 2025.
  • Year by year, Intangibles stood at $58.0 million in 2021, then rose by 1.89% to $59.1 million in 2022, then decreased by 13.72% to $51.0 million in 2023, then dropped by 21.72% to $39.9 million in 2024, then dropped by 17.12% to $33.1 million in 2025.
  • Business Quant data shows Intangibles for PAHC at $33.1 million in Q4 2025, $35.0 million in Q3 2025, and $36.5 million in Q2 2025.